germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
Salazar R, Vilar E, Martinez MP, Sastre J, Alonso V, Sevilla MI, Villabona C, Marazuela M, Castellano D, Diaz JA, Abad A, Blanco C,<br />
Llanos M.<br />
Preliminary results for 2001‐2005 of the Spanish Registry of the Gastro<strong>en</strong>teropancreatic NETs.<br />
NEUROENDOCRINOLOGY 2006; 83(1):46‐46.<br />
2,68<br />
Salvatierra A, Tarrats A, Gomez C, Sastre JM, Balana C.<br />
A case of c‐kit positive high‐gra<strong>de</strong> stromal <strong>en</strong>dometrial sarcoma responding to Imatinib Mesylate.<br />
GYNECOL ONCOL 101(3):545‐547.<br />
2,319<br />
Santarpia M, Altavilla G, Salazar F, Taron M, Rosell R.<br />
From the b<strong>en</strong>ch to the bed: individualizing treatm<strong>en</strong>t in non‐small‐cell lung cancer.<br />
Clin Transl Oncol 2006;8:71‐6<br />
Sastre J, Aranda E, Abad A, Gallego J, Manzano JL, Gomez A, Carrato A, Lopez E, Diaz‐Rubio E; TTD Group.<br />
UFT in combination with oxaliplatin: clinical phase I study in pati<strong>en</strong>ts with advanced or metastatic solid tumors.<br />
ANTI‐CANCER DRUG 2006 Apr;17(4):417‐21<br />
2,245<br />
Sirera R, Camps C, Llobat L, Berrocal A, Munoz‐Navarro M, Blasco A, Safont MJ, Gar<strong>de</strong> J, Juarez A, Taron M, Rosell R.<br />
The quantification of the catalytic subunit of telomerase is a prognostic factor in advanced non‐small cell lung cancer (NSCLC)<br />
pati<strong>en</strong>ts.<br />
LUNG CANCER‐J IASLC 52:S28‐S28.<br />
3,554<br />
Sirera R, Camps C, Llobat L, Munoz‐Navarro M, Marroqui A, Blasco A, Safont MJ, Gar<strong>de</strong> J, Taron M, Alberola V, Rosell R.<br />
Prognostic value of blood levels of vascular <strong>en</strong>dothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in<br />
advanced<br />
non‐small cell lung cancer. In: Lung Cancer.<br />
LUNG CANCER‐J IASLC p. S28‐S28.<br />
3,554<br />
Vela E, Roca X, Isamat M.<br />
Id<strong>en</strong>tification of novel splice variants of the human CD44 g<strong>en</strong>e.<br />
BIOCHEM BIOPH RES CO 343(1):167‐170.<br />
2,855<br />
Weiss GJ, Langer C, Rosell R, Hanna N, Shepherd F, Einhorn LH, Nguy<strong>en</strong> B, Paul S, McAndrews P, Bunn PA Jr, Kelly K. El<strong>de</strong>rly<br />
pati<strong>en</strong>ts b<strong>en</strong>efit from second‐line cytotoxic chemotherapy: a subset analysis of a randomized phase III trial of pemetrexed<br />
compared with docetaxel in pati<strong>en</strong>ts with previously treated advanced non‐small‐cell lung cancer. J CLIN ONCOL 2006 Sep<br />
20;24(27):4405‐11 13,598<br />
Zhong DS, Guo LZ, <strong>de</strong> Aguirre I, Liu XJ, Lamb N, Sun SY, Gal AA, Vertino PM, Zhou W.<br />
LKB1 mutation in large cell carcinoma of the lung.<br />
LUNG CANCER‐J IASLC 53(3):285‐294.<br />
3,554<br />
Pàgina 162/177
Change language